Description: The peptide is used to block Anti-Ubiquilin 4 Antibody (#CPA5244) reactivity. Form: Lyophilized powder Gene Symbol: UBQLN4 Alternative Names: C1orf6; CIP75; UBIN; Ubiquilin-4; Ataxin-1 interacting ubiquitin-like protein; A1Up; Ataxin-1 ubiquitin-like-interacting protein A1U; Connexin43-interacting protein of 75 kDa; CIP75Entrez Gene (Human): 56893Entrez Gene (Mouse) : 94232SwissProt (Human): Q9NRR5SwissProt (Mouse) : Q99NB8Purity : >85%Directions for Use : Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4°C for overnight or at room temperature for 2 hours.Quality Control : The quality of the peptide was evaluated by reversed-phase HPLC and by mass spectrometry.Storage/Stability : Shipped at 4°C. Store at -20°C for one year.
-
Western blot analysis of Ubiquilin 4 expression in HEK293T (A), K562 (B), NIH3T3 (C), mouse brain (D) whole cell lysates.
-
Immunohistochemical analysis of Ubiquilin 4 staining in human brain formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugacompact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.